Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Dose-Response Biomarker Study of Brexpiprazole Treatment in PTSD

NCT02934932 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT02934932
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02934932 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Dose-Response Biomarker Study of Brexpiprazole Treatment in PTSD
Lead sponsor
Duke University
Phase
Phase 2
Overall status
Terminated
Start date
April 25, 2017
Completion date
April 30, 2018
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post traumatic stress disorder